Mersana stock soared 200% premarket after Day One Biopharma agreed to buy the company for $25 per share plus potential ...

Spectrum Brands delivered Q4 EPS of $2.61 even as sales fell 5.2% and sees steady growth ahead in 2026, led by Pet Care and ...

Disney reported Q4 EPS of $1.11 alongside $22.5 billion in revenue, topping profit expectations but falling short on sales, ...

Circle’s Q3 earnings report underscores how stablecoins are becoming silent engines of U.S. financial power - embedding ...

Bitfarms slid 13% after missing Q3 EPS and revenue targets and announcing a shift toward AI infrastructure at its Washington ...

Sally Beauty posted Q4 2025 EPS of $0.55 and revenue of $947 million, both above expectations, and expects steady growth in ...

IBM stock gained after it introduced Quantum Nighthawk, a new 120-qubit processor that marks its most advanced quantum chip ...

TradeZero launches TZ1, a web-based trading platform featuring TradingView integration, customizable workspaces, and advanced ...

AMD stock rose 5.27% in premarket trading after the company forecast more than 35% annual sales growth over the next 3–5 ...

GlobalFoundries (GFS) topped Q3 2025 expectations with $1.688 billion in revenue and $0.44 EPS and issued optimistic guidance ...

Legend Biotech posted Q3 2025 EPS of -$0.11 and revenue of $272.33 million, supported by strong demand for CARVYKTI®.

Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains.